// App-Quantinova.ai

VPB0503 : Real- world effectiveness and safety of rivaroxaban in patients with non-valvular atrial fibrillation and venous thromboembolism in Saudi Arabia

Researchers

Presenter

  • F. Alqahtani

Principal Investigators

  • A. AlHarbi

Medical Centers

  • King Saud Univesrity, Dammam-Alkhobar, Ar Riyad, Saudi Arabia

  • King Saud Univesrty, ryidh, Ar Riyad, Saudi Arabia

  • King Saud Univesrty, ryidh, Ar Riyad, Saudi Arabia

Locations

  • Saudi Arabia

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Non-valvular atrial fibrillation

  • Venous thrombosis

  • Arrhythmia

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved